Sclerodermo renal crisis and recovery from end-stage renal disease

Seminars in Dialysis

Volumn 11, Issue 3, 1998, Pages 189-191

  Fenves, Andrew Z ^a   Murphy, J Shaun ^a   Emmett, Michael ^a  

^a BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 17944364376     PISSN: 08940959     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-139x.1998.tb00332.x     Document Type: Article

References (19)

1. Leroy EC, Fleischmann RM: The management of renal scleroderma, experience with dialysis, nephrectomy, and transplantation. Am J Med 64: 974-978, 1978
2. Ruggenenti P, Remuzzi G: Malignant vascular disease of the kidney: Nature of the lesions, mediators of disease progression and the case for bilateral nephrectomy. Am J Kidney Dis 27:459-475, 1996
3. Morris K, Connolly JO, O'Donnell PJ, et al.: Malignant hypertension and renal failure: Scleroderma renal crisis or renal artery stenosis. Nephrol Dial Transplant 4:1489-1491, 1994
4. Steen VD: Scleroderma renal crisis. Rheumatic Dis Clin N Am 22:871-878, 1996
5. Thurm RH, Alexander JC: Captopril in the treatment of scleroderma renal crisis. Ann Intern Med 144:733-735, 1984
6. Traum YM, Shapiro AP, Rodran GP, et al.: Hypertension and renal failure (scleroderma renal crisis) in progressive systemic sclerosis. Review of a 25 year experience with 68 cases. Medicine 62:335-352, 1984
7. Mitinick PD, Feig PU: Control of hypertension and reversal of renal failure in scleroderma. N Engl J Med 299:871-872, 1978
8. Wasner C, Cooke CR, Fries JF: Successful medical treatment of scleroderma renal crisis. N Engl J Med 299:873-875, 1978
9. Kohorst RW, Bay WH: Reversal of end-stage kidney failure in two scleroderma patients treated with anticoagulation. Am J Kidney Dis 2:347-348, 1982
10. Beckett VL, Donadio JV, Brennan LA, et al.: Use of captopril as early therapy for renal scleroderma: A prospective study. Mayo Clin Proc 60:763-771, 1985
11. Steen VD, Constantine JP, Shapiro AP, et al.: Outcome of renal crisis in systemic sclerosis: Relation to availability of angiotensin converting enzyme (ACE) inhibitors. Ann Intern Med 113:352-357, 1990
12. Strongwater SL, Galvanek EG, Stoff JS: Control of hypertension and reversal of renal failure in undifferentiated connective tissue disease by enalapril. Arch Intern Med 149:582-585, 1989
13. Hansen KJ, Tomasson RB, Craven TE, et al.: Surgical management of dialysis-dependent ischemic nephropathy. J Vasc Surg 21:197-214, 1995
14. Emmett M, Bengfort L, Warren E, Hull A: Recovery from end-stage renal disease. Kidney Int 16:886, 1977
15. Pickering G: Reversibility of malignant hypertension. Lancet 1:413-418, 1971
16. Woods JW, Blythe WB, Huffines WD: Management of malignant hypertension complicated by renal insufficiency. N Engl J Med 291:10-14, 1974
17. Heptinstall RH: Pathology of the Kidney (2nd ed). Boston, Little, Brown, 1974
18. Murray T, Goldberg M: Analgesic abuse and renal disease. Ann Rev Med 26:537-550, 1975
19. Murray TG, Goldberg M: Analgesic-associated nephropathy in the USA: Epidemiological, clinical and pathogenetic features. Kidney Int 13:64-71, 1978